Argent BioPharma Limited logo

Argent BioPharma Limited (H5O0)

Market Closed
XDUS XDUS
4.3M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
Previous Close
Day Range
0 0
Year Range
0 0
Want to track H5O0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

H5O0 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XDUS (EUR).

H5O0 Chart

Similar

61R
Laboratoires Euromedis S.A.
3.84
0%
Quantum BioPharma Ltd.
-
-
EZ1
Enzon Pharmaceuticals, Inc.
0.03
0%
Hände Health AG
-
-
LP2
Eurasia High Technology Inc.
2
+5.26%

Argent BioPharma Limited (H5O0) FAQ

What is the stock price today?

The current price is €0.00.

On which exchange is it traded?

Argent BioPharma Limited is listed on XDUS.

What is its stock symbol?

The ticker symbol is H5O0.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.3M.

Has Argent BioPharma Limited ever had a stock split?

No, there has never been a stock split.

Argent BioPharma Limited Profile

Biotechnology Industry
Healthcare Sector
- CEO
XDUS Exchange
- ISIN
Germany Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Argent Biopharma Ltd. stands at the forefront of the biotechnology industry, distinguished by its focus on developing and marketing novel therapeutic solutions. Dedicated to addressing unmet medical needs, the company prioritizes research in domains such as oncology, rare diseases, and chronic conditions, striving to bridge the gap between scientific discovery and clinical application. A hallmark of Argent Biopharma Ltd. is its unwavering commitment to pioneering scientific advancements and transitioning groundbreaking therapies from the laboratory to the marketplace.

Collaboration is a cornerstone of the company's strategy, involving partnerships with academic entities and research organizations to augment its drug candidate pipeline. Additionally, Argent Biopharma Ltd. is notable for its substantial investment in research and development, directing a significant portion of its resources towards clinical trials and navigating regulatory environments. In the financial landscape, the company is recognized as an innovator within the healthcare sector, influencing advancements in medical science and treatment options. This role underscores its dedication to enhancing patient care and contributing to the evolution of the biopharmaceutical field.

Products and Services

  • Oncology Therapies

    At the heart of Argent Biopharma Ltd.'s product lineup are cutting-edge oncology therapies designed to target various forms of cancer. These products leverage the latest in scientific research to offer more effective and personalized treatment options, aiming to significantly improve patient outcomes in the fight against cancer.

  • Rare Disease Treatments

    Focusing on the challenges posed by rare diseases, Argent Biopharma Ltd. develops specialized treatments aimed at these less common but often more complex conditions. By addressing diseases that traditionally receive less attention, the company contributes to expanding the therapeutic landscape for patients facing limited treatment options.

  • Chronic Condition Management

    Recognizing the ongoing nature of chronic conditions, Argent Biopharma Ltd. offers an array of therapies designed to manage long-term illnesses. These interventions focus on improving quality of life and managing symptoms, demonstrating the company's commitment to supporting patients through their healthcare journey.

Contact Information

Address: -
Phone: -